Kyle M. Kampman, MD, is affiliated with the Department of Psychiatry at the University of Pennsylvania Perelman School of Medicine in Philadelphia. Kampman has published research focused on addiction, including studies on opioid use disorder and cocaine dependence. The work includes clinical trials evaluating treatments such as extended-release naltrexone and buspirone for relapse prevention. Collaborators frequently include Anna Rose Childress, Antoine Douaihy, and others.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
